<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>High Variability in HLA-DRB1*03, a Predisposing Allele in Acute Lymphoblastic Leukemia</title>
	<subject_fa>Pediatric Hematology &amp; Oncology</subject_fa>
	<subject>Pediatric Hematology &amp; Oncology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;line-height:2;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Acute lymphoblastic leukemia (ALL) remains a significant health concern, particularly in children, with genetic predisposition playing a crucial role in its etiology. Among the predisposing HLA Class II alleles, &amp;mdash;DRB1*03 has emerged as a notable candidate associated with increased susceptibility to ALL. This study aims to investigate the extent of variability within the HLA-DRB1 alleles as genetic biomarkers and its implications in ALL pathogenesis. Through methods of polymerase chain reaction&amp;mdash;sequence-specific oligonucleotides (PCR-SSO) and sequence-based typing (SBT) analysis, our data revealed HLA-DRB1*16 as another genetic risk and HLA-DRB1*07 and HLA-DRB1*12 alleles as protective alleles in ALL patients. Further sequencing demonstrates a remarkable diversity in the HLA-DRB1*03 allele in ALL patients but none among the HLA-DRB1*16 alleles compared to normal samples. Our findings confirmed the association of HLA-DRB1 alleles with ALL and shed light on SNPs or mutations in the risk alleles. Genetic variability in HLA-DRB1 alleles is a significant factor to consider in improving outcomes in immunotherapy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Human leukocyte antigen, HLA-DRB1*03, HLA class II, Acute lymphoblastic leukemia, Pre-B ALL</keyword>
	<start_page>24</start_page>
	<end_page>33</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-1127-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Norfarazieda</first_name>
	<middle_name></middle_name>
	<last_name>Hassan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fara.hassan@usm.my</email>
	<code>100319475328460010861</code>
	<orcid>100319475328460010861</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400 UPM, Selangor, Malaysia</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Siti Zuleha</first_name>
	<middle_name></middle_name>
	<last_name>Idris</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zuleha@moh.gov.my</email>
	<code>100319475328460010862</code>
	<orcid>100319475328460010862</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathology, Faculty of Medicine &amp; Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Kian Meng</first_name>
	<middle_name></middle_name>
	<last_name>Chang</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drchangkm@gmail.com</email>
	<code>100319475328460010863</code>
	<orcid>100319475328460010863</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hematology, Hospital Ampang, Clinical Hematology Laboratory, Jalan Mewah Utara, Pandan Mewah, Ampang, Selangor 68000, Malaysia </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Raudhawati</first_name>
	<middle_name></middle_name>
	<last_name>Osman</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>raudhaosman@yahoo.com</email>
	<code>100319475328460010864</code>
	<orcid>100319475328460010864</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology Unit, Hospital Kuala Lumpur, Jalan Pahang, 50586 Wilayah, Persekutuan Kuala Lumpur, Malaysia </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hishamshah</first_name>
	<middle_name></middle_name>
	<last_name>Mohd Ibrahim</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drhishamshah@moh.gov.my</email>
	<code>100319475328460010865</code>
	<orcid>100319475328460010865</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pediatric Department, Hospital Kuala Lumpur, 50586 Wilayah, Persekutuan Kuala Lumpur, Malaysia</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jasbir Singh</first_name>
	<middle_name></middle_name>
	<last_name>Dhaliwal</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>jasbir@gmail.com</email>
	<code>100319475328460010866</code>
	<orcid>100319475328460010866</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Allergy and Immunology Research Centre, Institute for Medical Research, 50588 Jalan Pahang, Kuala Lumpur</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maha</first_name>
	<middle_name></middle_name>
	<last_name>Abdullah</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maha@upm.edu.my</email>
	<code>100319475328460010867</code>
	<orcid>100319475328460010867</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pathology, Faculty of Medicine &amp; Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
